Federal Appeals Court Upholds Injunction Against Hetero Labs in Otsuka Pharmaceutical Patent Dispute
In a recent decision, the U.S. Court of Appeals for the Federal Circuit issued a split ruling that upheld a lower court’s temporary injunction preventing Hetero Labs Ltd. from marketing a generic version of Otsuka Pharmaceutical Co.’s drug for neurological disorders. The panel’s ruling, delivered on Wednesday, reflects ongoing legal tensions in the pharmaceutical industry…